| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP | Director | Common Stock | 29.9K | $290K | $9.72 | Jun 11, 2025 | Direct |
| RECURSION PHARMACEUTICALS, INC. | Director | Class A Common Stock | 47.6K | $214K | $4.51 | Jun 18, 2025 | Direct |
| DYNAVAX TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 28.5K | Jun 11, 2025 | Direct | ||
| RECURSION PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 22K | Jun 18, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Jun 18, 2025 | 2 | $0 | 4 | Jun 23, 2025 | Director |
| DVAX | DYNAVAX TECHNOLOGIES CORP | Jun 11, 2025 | 2 | $0 | 4 | Jun 13, 2025 | Director |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Mar 17, 2025 | 2 | $0 | 4 | Mar 19, 2025 | Director |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Mar 15, 2025 | 0 | $0 | 3 | Mar 19, 2025 | Director |
| DVAX | DYNAVAX TECHNOLOGIES CORP | May 23, 2024 | 2 | $0 | 4 | May 28, 2024 | Director |
| DVAX | DYNAVAX TECHNOLOGIES CORP | May 26, 2023 | 2 | $0 | 4 | May 31, 2023 | Director |
| DVAX | DYNAVAX TECHNOLOGIES CORP | May 26, 2022 | 2 | $0 | 4 | May 27, 2022 | Director |
| DVAX | DYNAVAX TECHNOLOGIES CORP | Dec 10, 2021 | 2 | $0 | 4 | Dec 14, 2021 | Director |
| DVAX | DYNAVAX TECHNOLOGIES CORP | Dec 10, 2021 | 0 | $0 | 3 | Dec 14, 2021 | Director |